Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases
Chronic Obstructive Lung Disease Clinical Trials
A listing of Chronic Obstructive Lung Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 Last
Arizona
Novartis Investigative Site
Additional Locations Arizona
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Chandler Arizona 85224
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
California
Novartis Investigative Site
Fresno California 93726
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Fullerton California 92835
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Yorba Linda California 92886-7921
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Yorba Linda California 92886
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Colorado
Novartis Investigative Site
Boulder Colorado 80304
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Wheat Ridge Colorado 80033
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Florida
Emerald Coast Research Associates
Panama City Florida 32405
Research Study for Chronic Obstructive Pulmonary Disease (COPD)
View More »
Novartis Investigative Site
Lynn Haven Florida 32444
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Miami Florida 33173
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Georgia
Novartis Investigative Site
Conyers Georgia 30094
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Illinois
Novartis Investigative Site
River Forest Illinois 60305
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Skokie Illinois 60076
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Kentucky
Novartis Investigative Site
Lexington Kentucky 40509
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Louisiana
Novartis Investigative Site
Sunset Louisiana 70584
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Massachusetts
Tufts Medical Center
Boston Massachusetts 02111
A clinical research study of Breathe NIOV Ventilator for the treatment of Chronic Obstructive Lung Disease
Novartis Investigative Site
Fall River Massachusetts 02720
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
North Dartmouth Massachusetts 02747
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Michigan
ClinSite, LLC
Ann Arbor Michigan 48106
Diagnosed with COPD, Chronic Bronchitis or Emphysema?
Minnesota
Novartis Investigative Site
Minneapolis Minnesota 55402
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Plymouth Minnesota 55441
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Missouri
Novartis Investigative Site
St. Charles Missouri 63301
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
St. Louis Missouri 63128
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
St. Louis Missouri 63141
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Nebraska
Novartis Investigative Site
Fremont Nebraska 68025
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Lincoln Nebraska 68510
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Omaha Nebraska 68114
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
New Jersey
Novartis Investigative Site
Cherry Hill New Jersey 08003
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
New Mexico
Novartis Investigative Site
Albuquerque New Mexico 87108
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
New York
Novartis Investigative Site
Brooklyn New York 11229
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Brooklyn New York 11234
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Great Neck New York 11021
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Massapequa New York 11758
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
New Windsor New York 12553
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
View More »
Novartis Investigative Site
New York New York 10028
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
North Carolina
Novartis Investigative Site
Charlotte North Carolina 28207
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Ohio
Novartis Investigative Site
Cincinnati Ohio 45242
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Cincinnati Ohio 45245
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Cincinnati Ohio 45231
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Columbus Ohio 43213
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Oregon
Novartis Investigative Site
Medford Oregon 97504
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Medford Oregon 97504-8741
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Portland Oregon 97213
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Pennsylvania
Novartis Investigative Site
Langhorne Pennsylvania 19047
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Pittsburgh Pennsylvania 15243
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Pottstown Pennsylvania 19464
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Tipton Pennsylvania 16684
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Rhode Island
Novartis Investigative Site
East Providence Rhode Island 02914
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
South Carolina
Novartis Investigative Site
Fort Mill South Carolina 29707
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
First 1 2 Last